Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Acumen Pharmaceuticals, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2023 4 Stalfort John A III (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $5.2, valued at $130k
06/07/2023 4 Stoppel Laura (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $5.2, valued at $130k
06/07/2023 4 Porter Derrell (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $5.2, valued at $130k
06/07/2023 4 Ives Jeffrey L. (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $5.2, valued at $130k
06/07/2023 4 Fountain Nathan B (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $5.2, valued at $130k
06/07/2023 4 Drapkin Kimberlee C (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $5.2, valued at $130k
01/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2023 4 Porter Derrell (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 50,000 options to buy @ $5.46, valued at $273k
01/04/2023 3 Porter Derrell (Director) has filed a Form 3 on Acumen Pharmaceuticals, Inc.
01/03/2023 4 Zuga Matt (CFO and Chief Business Officer) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Exercised 50,000 options to buy @ $1.19, valued at $59.5k
09/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/07/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/21/2022 4 RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $3.59, valued at $89.8k
06/17/2022 4 Fountain Nathan B (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $3.59, valued at $89.8k
06/17/2022 4 Stoppel Laura (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $3.59, valued at $89.8k
06/17/2022 4 Ives Jeffrey L. (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $3.59, valued at $89.8k
06/17/2022 4 Stalfort John A III (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $3.59, valued at $89.8k
06/17/2022 4 Sevigny Jeffrey (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $3.59, valued at $89.8k
06/17/2022 4 Drapkin Kimberlee C (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $3.59, valued at $89.8k
04/04/2022 4 Drapkin Kimberlee C (Director) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 50,000 options to buy @ $4.01, valued at $200.5k
04/04/2022 3 Drapkin Kimberlee C (Director) has filed a Form 3 on Acumen Pharmaceuticals, Inc.
01/21/2022 4 Zuga Matt (CFO and Chief Business Officer) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 150,000 options to buy @ $5.19, valued at $778.5k
01/21/2022 4 Siemers Eric (Chief Medical Officer) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 90,000 options to buy @ $5.19, valued at $467.1k
01/21/2022 4 OConnell Daniel Joseph (President and CEO) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 455,000 options to buy @ $5.19, valued at $2.4M
01/21/2022 4 Barton Russell (COO) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Granted 135,000 options to buy @ $5.19, valued at $700.7k
12/02/2021 4 OConnell Daniel Joseph (President and CEO) has filed a Form 4 on Acumen Pharmaceuticals, Inc.
Txns: Exercised 1,118 options to buy @ $4.47, valued at $5k
07/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy